Aug 2026· Genes· Vol 17, pp. 982· 0 citations· 47 references
Medicine
TL;DR
An association between the expression of lactoferrin (LTF) and its receptor, LDL receptor-related protein 11 (LRP11), and susceptibility to severe COVID-19 was identified, highlighting a potentially relevant signaling axis in disease pathogenesis.
Abstract
Background/Objectives: The molecular mechanisms underlying susceptibility to severe COVID-19 remain incompletely understood. We aimed to identify the signaling pathways associated with disease severity by integrating transcriptomic data and characterizing ligand–receptor interactions involved in the host response to SARS-CoV-2 infection. Methods: We integrated publicly available bulk RNA-sequencing data from nasopharyngeal (NP) swabs (GSE152075) and single-cell RNA-sequencing data from bronchoalveolar lavage fluid samples (GSE145926). Analyses focused on secreted ligands and their cognate receptors and were performed in relation to demographic and clinical characteristics associated with susceptibility to severe COVID-19, including sex, age, and viral load. Results: Patients with characteristics associated with increased susceptibility to severe disease, including male sex, advanced age, and high viral load, exhibited transcriptional programs enriched for inflammatory and immune-response pathways. In contrast, individuals with lower susceptibility displayed reduced expression of 43 ligand genes compared with matched negative controls, suggesting distinct secretory programs associated with the host response to infection. We identified an association between the expression of lactoferrin (LTF) and its receptor, LDL receptor-related protein 11 (LRP11), and susceptibility to severe COVID-19. LRP11 was predominantly expressed in human pulmonary epithelial cells, and its expression increased during SARS-CoV-2 infection in monkeys. Conclusions: Our findings provide insight into the molecular mechanisms associated with susceptibility to severe COVID-19 through the analysis of ligand and receptor expression in nasopharyngeal swabs and bronchoalveolar lavage fluid samples. The association between LTF and LRP11 highlights a potentially relevant signaling axis in disease pathogenesis and provides a rationale for future functional studies aimed at clarifying its role in COVID-19 severity.
Findings identify transcriptomic signatures associated with potential COVID-19 susceptibility across innate, adaptive, and vascular immune-related axes and provide an exploratory framework for risk classification and potential precision prevention.
Yu-Ting Xin, Chao Yi, Wei Zhu et al.· Frontiers in Immunology· 0 citations
IL1R2 identifies a highly inflammatory monocyte state associated with COVID-19 immune dysregulation, supporting its potential role as a complementary prognostic biomarker and therapeutic target.
Yi-Ying Yang, Fang Yu, Mu-Yuan Li et al.· Shock· 0 citations
Preliminary evidence that vtRNAs are dysregulated in PBMCs from patients with severe COVID-19 is provided, suggesting that these non-coding RNAs may be involved in host molecular responses associated with severe SARS-CoV-2 infection.
Zahra Firoozi, Elham Mohammadisoleimani, Amirreza Mazloomi et al.· Archives of Biochemistry and...· 0 citations
Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection and remains a major cause of mortality in critically ill patients. Multiple forms of programmed cell death (PCD) may contribute to immune dysregulation and organ injury, but their transcriptional patterns across disease severi...
Jing Xu, Peng Wang, Ming-Zhao Xu· Frontiers in Cell and Develo...· 0 citations
Intratracheal instillation exposure to ATBC may aggravate fibrosis progression on the basis of pre‑existing lung injury, with MMP1 serving as a core effector molecule, and preliminary experimental support for the safety assessment of plasticizers following respiratory tract exposure is offered.
Dajia Fu, Xiuxiu Ding, Xinyi Cai et al.· Gene· 0 citations
A macrophage-centered anoikis-related immune signature in atherosclerosis is defined and HAVCR2 is identified, together with CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1, as potential biomarkers and candidate targets for future diagnostic and therapeutic investigation.
Qiang Shen, Zheng-Feng Fan, Jin-Cheng Hou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.